Rating Change
Barclays analysts reiterated a Equal-Weight rating on Agilon Health, Inc. (NYSE:AGL) on August 06, 2026.
reiterateNYSE:AGL
Barclays Reiterates Equal-Weight Rating on Agilon Health, Inc. (AGL)
Rating Change Barclays analysts reiterated a Equal-Weight rating on Agilon Health, Inc. (NYSE:AGL) on August 06, 2026. Market Context Agilon Health, Inc.
Market Context
Agilon Health, Inc. operates in the Healthcare sector. The stock currently trades at $91.19 with a market capitalization of $244.3M.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Agilon Health, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Agilon Health, Inc.
Among the 10 most recent ratings: 3 Buy, 6 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 06, 2026 | Evercore ISI Group | In-Line | N/A |
| Aug 06, 2026 | Barclays | Equal-Weight | N/A |
| Jul 23, 2026 | Citigroup | Sell | N/A |
| Jul 13, 2026 | Wells Fargo | Overweight | N/A |
| May 26, 2026 | Barclays | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View AGL Stock Page
Frequently Asked Questions
What does a Equal-Weight rating mean for AGL?
A Equal-Weight rating from Barclays reflects the analyst's outlook on Agilon Health, Inc. (NYSE:AGL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AGL forecast page.